Funds and ETFs Hua Medicine (Shanghai) Ltd.
Equities
2552
KYG4644K1022
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 HKD | -0.62% | +0.63% | -18.78% |
Mar. 28 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
ETFs positioned on Hua Medicine (Shanghai) Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.66% | 4 M€ | -27.92% | ||
0.00% | 0 M€ | +3.30% | - | |
0.00% | 4 M€ | -4.41% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.78% | 202M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- 2552 Stock
- Funds and ETFs Hua Medicine (Shanghai) Ltd.